Memorandum from NZSG
Posted Thursday April 6, 2023
The NZSG Working Group for IBD Medication after discussion with NZSG members, Pharmac and pharmaceutical company representatives have written an e-guidance document on ustenkinumab treatment and ongoing maintenance doses. Please find this on the NZSG website.
Gallery
Related Articles
Commercial composting in the Green Endoscopy Unit- the next goal for waste reduction?
Friday April 19, 2024
Written and Shared by the NZSG Sustainability Working Group.
Gastro News from Around the Globe
Wednesday April 17, 2024
The Society receives information from many organisations around the globe as well as closer to home. We'd like to share ...
FYI - Pharmacy Information
Tuesday April 16, 2024
An Alert multiple severe lead toxicity associated with the use of some Ayurvedic (traditional Indian medicine) products ...